FDA Vaccine Advisory Board Member: We Don't Need More Info on J&J Vaccine, Pausing It Risks More People Getting COVID

On Wednesday's broadcast of CNN's "Situation Room," Dr. Paul Offit, a member of the FDA's Vaccines and Related Biological Products Advisory Committee, said there's sufficient information to make a decision on whether to resume the Johnson and Johnson vaccine and criticized the pause by stating, "There are no risk-free choices, just choices that take different risks."